Case reports

A Young Lady With a Rash (2006)

Case_Report_December_2006_iconDecember 2006
Issue 4, Vol. 1

DOI: 10.1594/eaaci.net2006/CR/3-161206

Claude Luder,Sabine Schneiter,Jobst Greeve ,Werner-Josef Pichler*

Inselspital-University Hospital Berne, CH 3010 Berne, Switzerland

Correspondence: This email address is being protected from spambots. You need JavaScript enabled to view it.

Click here to download the PDF Version!!

An 18 year-old female patient was admitted with high fever (>39.5°C) for 3 days, dyspnoea, rash with edema of the face, both hands and feet (Fig. 1A and B). She showed diffuse lymphadenopathy and an enlarged liver.

1033 1034

At the age of 5 years, the patient was diagnosed with celiac disease. Since that time she adhered to a strict gluten-free diet. At age 12 the patient developed an insulin dependent diabetes mellitus (IDDM). Despite intensified insulin therapy, control of hyperglycemia had been difficult during adolescence. Four weeks prior to the actual admission, focal diabetic neuropathy developed with severe pain in the left leg. Treatment with carbamazepin at a dose of 3 X 400 mg for seven days was started. Because of persistence of severe pain attacks gabapentin was added in increasing doses up to 3 X 400 mg. Under this treatment a rash developed after 14 days.

* What is your differential diagnosis in this acute ill young patient with fever, rash and diffuse edema?

Last updated 01 March 2015
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback